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The Cry1Ia12 entomotoxin from a Brazilian Bacillus thuringiensis strain is currently being expressed in cotton cultivars to confer
resistance to insect-pests. The present study aimed to assess the eﬀects of a diet containing Cry1Ia12 protein on growing rats. A
test diet containing egg white and Cry1Ia12 (0.1% of total protein) as a protein source was oﬀered to rats for ten days. In addition,
an acute toxicity bioassay was performed in rats with a single oral dose of the entomotoxin (12 mg/animal). No adverse eﬀects
were observed in the animals receiving the test diet when compared to those receiving a control diet (egg white). The analysed
parameters included relative dry weight of internal organs, duodenum histology, blood biochemistry, and nutritional parameters.
The results of the acute toxicity test showed no mortality or behaviour alteration. Thus, Cry1Ia12 toxin at the tested concentration
does not cause deleterious eﬀects on growing rats when incorporated in the diet for 10 days.
1.Introduction
Cotton, Gossypium hirsutum L., is grown worldwide pri-
marily as a source of ﬁbre for textile manufacturing and
Brazil is one of the largest producers in the world. However,
the production of this commodity is highly aﬀected by
large losses caused mainly by insect-pests, such as Anthono-
mus grandis (Coleoptera: Curculionidae) and Spodoptera
frugiperda (Lepidoptera: Noctuidae) [1]. In general, the
control of these insects requires heavy chemical pesticides,
which are very expensive. In addition, the use of pesticides
causes considerable risks to human health, the environment,
nontarget organisms, and can promote the development of
resistance in insects [2]. The most promising cost-eﬀective
andsustainablemethodforcontrollingthecottonbollweevil
(A. grandis) is the development of genetically resistant plants
[1].
Genetic engineering has been widely used as an impor-
tant tool in cotton production to control target insect-
pests. Among the cotton cultivars available on the market,
those genetically modiﬁed to express insecticidal genes (Cry
genes) from Bacillus thuringiensis (Bt) stand out among the
mostcommercialised.However,thesegenesconferresistance
to major lepidopteran insect-pests [3] but are ineﬃcient2 Journal of Biomedicine and Biotechnology
regarding the cotton boll weevil. In this context, a toxin
belonging to the Cry1 class (termed Cry1Ia12) exhibiting
entomotoxic activity against A. grandis and S. frugiperda
has recently been isolated from B. thuringiensis S811 and
characterised [1].
Numerous data from toxicity studies have not shown
any signiﬁcant adverse eﬀects of Cry proteins on mammals,
including humans [4, 5]. Nevertheless, it is mandatory that
a rigorous assessment be performed of each newly isolated
Cry protein for the generation of GM cotton. To assess the
potential risks of transgenic organisms, the International
Food Biotechnology Council (IFBC) has reported the safety
evaluation of GMOs. Similarly, groups like the Organisation
for Economic Cooperation and Development (OECD), the
Food and Agriculture Organisation of the United Nations
(FAO), the World Health Organisation (WHO), and the
International Life Science Institute (ILSI) have established
safety assessment guidelines to assure that foods produced
from biotechnology-derived products are as safe as those
produced from conventionally bred crops [6]. The risk
assessment of a biotechnology-derived crop is a comparative
safety assessment using conventional food as reference, and
such analyses are conducted in accordance with the concept
of substantial equivalence [7]. The assessment process con-
siders two main categories of potential risk: those related to
thepropertiesandfunctionsoftheintroducedprotein(s)and
those resulting from insertion of the introduced gene(s) into
the plant genome that might theoretically cause unintended
(pleiotropic) eﬀects [8].
The generation of a GM plant normally requires a
signiﬁcant investment of time, and consequently, it is very
importanttoevaluatethepropertiesofthetransgenicprotein
with regard to toxicity, allergenicity, and antinutritional
potential before its introduction into the target plant [9].
This procedure ensures that the protein inserted in the
genetically modiﬁed plant is safe for human health. It also
aims to answer whether possible nutritional or pathological
alterations are insigniﬁcant and whether they are related
to the Cry toxin or to the changes in the genome of the
transgenic cotton [5]. Thus, the present work aimed to assess
the eﬀects of a Cry1Ia12-containing diet (100mg/Kg or 0.1%
total protein) on growing rats, as well as to analyse the
relative wet and dry weight of internal organs, duodenum
histology, and blood biochemistry. In addition, an acute
toxicitybioassaywasperformedinratswithasingleoraldose
oftheentomotoxintoassessthemortalityrateandbehaviour
alteration of the animals.
2.MaterialsandMethods
2.1. Construction of E. Coli Expression Vector pET101-
Cry1Ia12. The E. Coli expression vector pET101-Cry1Ia12
was constructed as described previously [1]. The Cry1Ia12
gene was selected based on its insecticidal speciﬁcity and
activity against the cotton insect-pests A. grandis and S.
frugiperda. This gene is currently being introduced into
cotton cultivars with the goal of generating resistance against
insect attack.
2.2. Recombinant Cry1Ia12 Toxin Expression and Puriﬁ-
cation. E. Coli BL21 Star (DE3) cells transformed with
pET101-Cry1Ia12 were grown at 37◦C in 500mL of
Luria-Bertani broth at 200rpm agitation with 200μg/mL
ampicillin until O.D.600 = 0.6–0.8. The expression of
Cry1Ia12 was induced by addition of 1mM isopropyl-beta-
D-thiogalactopyranoside (IPTG) when the culture reached
O.D.600 = 0.7. Sixteen hours after induction, the cells
were harvested by centrifugation at 4,000×g. The pel-
let containing the His-tagged Cry1Ia12 protein was then
resuspended in the lysis buﬀer (50mM sodium phosphate
buﬀer, 300mM NaCl, and 0.5% Triton X-100, pH 7.0). The
crude extract was sonicated three times for 5min (large
tip, Virsonic Cell Disrupter—Model 16-850), centrifuged
at 10,000×gf o r2 0 m i na t4 ◦C, and the supernatant was
analysed by 12% SDS-PAGE [10]. The supernatant was also
used for the puriﬁcation of recombinant Cry1Ia12 using
Ni2+ nitrilotriacetic acid aﬃnity resin (Ni-NTA, QIAGEN)
treated with equilibration buﬀer (50mM sodium phosphate
buﬀer, 300mM NaCl, 10mM imidazole pH 7.0). The
supernatant containing E. Coli expressing recombinant His-
tagged Cry1Ia12 protein was incubated for 30min within
the equilibrated column. The column was then ﬁrst washed
with 100mL of equilibration buﬀer and subsequently with
100mL of the same buﬀer containing 20mM imidazole. The
recombinant His-tagged Cry1Ia12 protein was eluted with
6mL of equilibration buﬀer containing 250mM imidazole.
All the steps were run at a ﬂow rate of 2mL/min. The
elutedproteinwasdialysedagainstwaterat4◦C.Thepuriﬁed
protein was quantiﬁed according to Lowry’s method [11].
2.3. Animals. Eighteen male Wistar rats were obtained from
the Animal Facilities of the Universidade Federal do Cear´ a
(UFC). The rat weights were in the range of 55–60g at the
beginning of the treatments, which followed the procedures
approved by the Commission of Ethics in Animal Research
of the Universidade Federal do Cear´ a—CEPA/UFC.
2.4. Diets. For this assay, three diets were prepared: (1) a
control diet containing egg white (EW) as reference protein
due to its high biological value [12]; (2) a test diet containing
Cry1Ia12 protein (99.9g of egg-white protein and 0.1g of
Cry1Ia12); (3) a nonprotein diet (NPC). Diets 1 and 2 were
prepared to contain the equivalent of 100-g protein/kg diet.
The Cry1Ia12 protein comprised 0.1% of total protein. The
NPC diet was fed to allow the determination of various
nutritional parameters (Table 1).
2.5. Animal Feeding Trial. Wistar male rats were weaned at
21 days of age and given a commercial stock diet until their
weights reached 55–60g. They were then fed the control
diet (egg white as the sole source of protein) ad libitum for
three days as a period of adaptation to pulverised diet. Then,
the animals were selected according to body weight. It was
allowed for weight variation of up to 10g within the group
a n du pt o5ga m o n gg r o u p s .
The animals were divided into three groups of six rats
each, individually housed in screen-bottomed cages andJournal of Biomedicine and Biotechnology 3
Table 1: Composition (g/kg) of the NPC, EW, and experimental diets
∗.
Ingredients Diets
NPC EW Cry1Ia12
Maize starch 475 342.55 342.55
Glucose 150 150 150
Maize oil 150 150 150
Vitamin mix
∗∗ 50 50 50
Mineral mix
∗∗∗ 50 50 50
Neoﬁbre
∗∗∗ 125 125 125
Egg White (75.5%) — 132.45 132.35
Cry1Ia12 — — 0.1
∗Cry1Ia12: Cry1Ia12 protein; NPC: nonprotein control; EW: egg-white protein.
∗∗Vitamin mix (g/kg): vitamin B12 (100%), 0.02; folic acid, 0.04; biotin (1%), 4.0; pyridoxine HCl, 0.04; thiamine HCl, 0.06; riboﬂavin (99%), 0.21; Ca-
pantothenate (45%), 1.2; nicotinic acid, 4.0; inositol, 4.0; p-amino-benzoic acid, 12.0; choline chloride (50%), 24.0; maize starch, 950.43.
∗∗∗Mineral mix (g/kg): calcium citrate, 296.1; calcium carbonate (40%), 65.8; copper carbonate, 1.1; magnesium carbonate, 34.3; zinc carbonate, 0.48; ferric
citrate, 9.1; magnesium chloride · 6H2O, 5.82; sodium chloride, 74.0; potassium chloride, 119.5; monobasic calcium phosphate, 108.2; dibasic potassium
phosphate, 210.1; sodium ﬂuoride, 0.48; potassium iodate, 0.1; magnesium sulphate, 75.4.
∗∗∗∗Neoﬁbre (Nuteral, 80% ﬁbre, Fortaleza, Brazil).
fed the control (egg-white), nonprotein containing (NPC),
or test diet (0.1% of Cry1Ia12 toxin) for ten days. Food
and water were supplied ad libitum. Rats total weight,
diet spillage, and refused diet were recorded daily. Faeces
were collected during the last ﬁve days of the experimental
period, bulked, freeze-dried, weighed, and ground in a coﬀee
grinder. At the end of the trial, the rats were euthanised by
cervical dislocation and the internal organs were dissected.
The organs were, then, freeze-dried whereas the carcasses
were dehydrated in an oven at 100◦C for 24h. Dry weights
were recorded before incorporating the organs into their
original carcasses, which were then ground and kept in a
desiccator until subsequent analyses.
2.6. Chemical Analyses. Diets, carcasses, and ground fecal
samples were analysed for moisture and total nitrogen
content [13]. The data were used to calculate apparent
protein digestibility, net protein utilization (NPU), and
biological value, according to Miller and Bender [14]. All
the results were calculated for each rat and the mean was
calculated within each group.
2.7. Blood Biochemistry. Blood samples were collected and
serum was separated from cells very rapidly. Blood bio-
chemistry determinations were performed manually with
a spectrophotometer (Thermo Spectronic, model Genesys
10, Rochester, USA). Parameters were total protein (biuret
method), albumin (bromocresol green method), alkaline
phosphatase (modiﬁed Roy’s method), blood urea nitrogen
(colorimetric enzymatic method), alanine aminotransferase
(ALT), and aspartate aminotransferase (AST) (Reitman and
Frankel methods). All methodologies are well described in
the manufacturer instructions (Bioclin kits, QUIBASA Basic
Chemical Ltda, Belo Horizonte, Brazil).
2.8. Histopathological Analyses. The stomach, intestine, cae-
cumandcolon,liver,pancreas,kidneys,heart,thymus,lungs,
and spleen were dissected and weighed immediately. The
relative organ dry weights (ratios of organ weight to ﬁnal
body weight) were calculated. Samples of the small intestine
(duodenum) were collected and immediately ﬁxed in 10%
formaldehyde for 24h. Following a routine procedure, the
ﬁxed tissues were embedded in paraﬃna n d5μm thick tissue
sections were stained with haematoxylin and eosin (H&E)
and analysed by light microscopy.
2.9. Statistical Analyses. T h ed a t aw e r es u b j e c t e dt oao n e -
way analysis of variance (ANOVA) and the signiﬁcance
among means was determined by Tukey’s test.
3. Results
3.1. Recombinant Cry1Ia12: E. Coli Expression and Puriﬁ-
cation. E. Coli strain BL21 Star (DE3) harbouring the
pET101-Cry1Ia12 construct was induced with 1mM IPTG
to express recombinant His-tagged Cry1Ia12 protein. SDS-
PAGE analysis of E. Coli extracts showed a diﬀerential band
corresponding to the expected 74-kDa recombinant His-
tagged Cry1Ia12 protein (Figure 1). No additional bands
were identiﬁed in the noninduced cells with empty pET101
vector. Around 2mg/L of His-tagged protein was puriﬁed
using Ni2+-NTA aﬃnity chromatography from sonicated E.
Coli crude extract. Using these conditions, the Cry1Ia12
protein was produced in large scale (150mg) to be used in
the biological assays.
3.2. Nutritional Parameters. Cry1Ia12 toxin was included
in the diet of growing Wistar rats representing 0.1% of
the total protein (Table 1). Body weight gain and diet
intake were measured daily and the following nutritional
parameters: NPU, protein digestibility, and biological value,
were calculated (Table 2). The total weight gain of rats fed
Cry1Ia12 toxin was not signiﬁcantly diﬀerent from that of
rats fed the control diet (egg white as the sole source of
protein). On the other hand, total food intake for both diets
was 50% higher than that of rats fed the NPC diet. The4 Journal of Biomedicine and Biotechnology
Table 2: Nutritional parameters of rats fed the Cry1Ia12 toxin diet compared to those of rats fed the egg white (EW) and nonprotein (NPC)
diets.
Diet
∗
NPC EW Cry1Ia12
Initial body weight
δ (g) 71.96±3.95b 70.89±5.72a 70.98±5.83a
Final body weightδ (g) 56.7±1.67b 110.10±7.66a 101.31±6.42a
Daily diet intakeδ (g) 5.11±1.00b 11.8±1.17a 11.29±0.84a
Net Protein Utilization (NPU)¶ % — 91.05±3.20a 90.76±4.81a
Protein Digestibilityd % — 91.27±9.71a 99.98±9.94a
Biological Valued % — 90.67±9.41a 99.99±9.77a
Values are means±standard deviation (n = 6). Values in a row with diﬀerent letters diﬀer signiﬁcantly (P<. 05).
∗For key to diets see Section 2.
δPer rat.
¶Per group of 6 rats.
14 3 2
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Figure 1: SDS-PAGE (12%) proﬁle showing the expressed and
puriﬁedrecombinantCry1Ia12protein.Lane1:MarkerBenchMark
Protein Ladder (INVITROGEN). Lane 2: E. Coli crude extract
induced with 1mM IPTG after 16h expressing recombinant
Cry1Ia12 protein, sonicated and centrifuged. Arrows indicate the
expressed 74-kDa recombinant Cry1Ia12. Lane 3: Noninduced E.
Coli strain BL21Star (DE) containing the expression vector without
insert was used as a negative control of the expression. Lane 4:
Recombinant Cry1Ia12 protein puriﬁed by using Ni-NTA column.
Arrow shows the expected puriﬁed 74-kDa recombinant Cry1Ia12
protein.
low growth rate observed in rats fed the NPC diet may be
related to food intake since these rats consumed much less
food than those on the control diet. However, the rats fed the
Table 3: Relative faecal dry matter (g) and nitrogen output (g)
of rats fed the egg white control (EW) and test diets (Cry1Ia12)
calculated for test days 6 to 10.
Parameters¶ Diets
EW Cry1Ia12
Diet intake (D) 70.64±7.53a 62.32±6.47a
N intake (N) 1.12±0.09a 0.99±0.17a
Faecal output (F) 3.98±0.67a 3.17±0.69a
Faecal N (FN) 0.16±0.04a 0.14±0.05a
F/D×100 5.27±1.01a 5.58±0.44a
FN/N×100 13.22±3.27a 15.05±4.12a
Values are means±standard deviation (n = 6).
aValues in a row with diﬀerent letters diﬀer signiﬁcantly (P<. 05).
¶gp e rr a t .
Cry1Ia12 toxin diet did not exhibit a signiﬁcant diﬀerence
when compared to rats fed the control diet (P>. 05)
(Table 2). No signiﬁcant diﬀerence was observed in NPU, in
vivo protein digestibility, or protein biological value (P>. 5)
in rats fed the Cry1Ia12 toxin diet when compared to those
on the egg white diet. Similarly, no diﬀerence in N balance
was detected between these groups (Table 3).
3.3. Blood Biochemistry Analysis. The results of blood bio-
chemical parameters analysis (Table 4) revealed no signif-
icant diﬀerence between values (total protein, albumin,
alkaline phosphatase, blood urea nitrogen, alanine amino-
transferase, and aspartate aminotransferase) for rats fed the
Cry1Ia12toxindietandthoseofratsfedtheeggwhitecontrol
diet.
3.4. Organ Weights and Histopathology. The absolute and
relative organ wet and dry weights (Table 5)w e r en o t
signiﬁcantly diﬀerent between the rats fed the Cry1Ia12 diet
and those on the control diet. On the other hand, the small
intestine, heart, kidneys, and lungs of rats fed the NPC diet
were signiﬁcantly larger than those of standard control diet.
Furthermore, the NPC diet induced atrophy of the thymus
when compared to the control diet. Details regarding organ
wet and dry weights are summarised in Table 5.Journal of Biomedicine and Biotechnology 5
Table 4: Blood biochemical parameters of rats fed the nonprotein (NPC), egg white (EW), and test (Cry1Ia12) diets.
Parameter Diet
NPC EW Cry1Ia12
Protein (g/dL) 6.18±0.26b 8.10±0.66a 7.98±0.36a
Albumin (g/dL) 4.24±0.22b 5.40±0.16a 5.60±0.22a
Urea blood nitrogen (mg/dL) 15.90±0.70b 4.80±0.50a 5.20±1.00a
Alkaline phosphatase (U/mL) 107.57±10.98b 139.00±11.20a 133.06±12.89a
ALT (U/mL) 16.70±1.60a 15.67±0.60a 15.03±1.00a
AST (U/mL) 18.96±1.90a 17.30±1.20a 16.95±1.32a
Values are means±standard deviation (n = 6). Values in a row with diﬀerent letters diﬀer signiﬁcantly (P<. 05).
Table 5: Relative organ wet and dry weights (g/100g wet or dry body weight) of rats fed the nonprotein (NPC), egg white (EW), and test
(Cry1Ia12) diets.
Organ Diet
NPC EW Cry1Ia12
Stomach wet 1.28±0.19a 0.99±0.07a 0.98±0.07a
dry 0.75±0.05a 0.64±0.10a 0.57±0.04a
Intestine wet 5.84±0.51b 4.06±0.44a 4.49±0.51a
dry 2.96±0.19a 2.32±0.30b 2.36±0.27b
Caecum and colon wet 2.14±0.33a 1.97±0.36a 1.98±0.18a
dry 1.12±0.20a 1.04±0.10a 1.04±0.08a
Liver wet 5.13±0.66a 5.43±0.58a 4.95±0.40a
dry 4.70±0.40a 4.49±0.40a 4.41±0.40a
Pancreas wet 0.29±0.07a 0.42±0.12a 0.36±0.07a
dry 0.30±0.05a 0.35±0.06a 0.33±0.08a
Heart wet 0.55±0.04a 0.50±0.05a 0.52±0.03a
dry 0.39±0.03a 0.31±0.04b 0.34±0.02b
Kidneys wet 1.26±0.08a 1.02±0.07b 1.09±0.16ab
dry 0.95±0.08a 0.69±0.07b 0.76±0.11b
Lungs wet 0.86±0.10a 0.90±0.22a 0.89±0.16a
dry 0.58±0.06a 0.47±0.05b 0.50±0.07ab
Thymus wet 0.23±0.08a 0.42±0.04b 0.40±0.06b
dry 0.18±0.05a 0.28±0.05b 0.29±0.04b
Spleen wet 0.21±0.02a 0.36±0.06b 0.31±0.02b
dry 0.20±0.02a 0.23±0.03a 0.22±0.02a
Values in a row with diﬀerent letters diﬀer signiﬁcantly (P<. 05); n = 6.
The histopathological analysis (Figure 2) revealed no
alteration in duodenum of rats fed Cry1Ia12 toxin. The villi
and microvilli were continuous and no alteration in the
nuclei of enterocytes or increase in defence cell number was
noted.
4. Discussion
The Cry toxins of Bacillus thuringiensis have been the object
of many recent studies to assess their safety to nontarget
organisms [15]. In this context, it is important the carrying
out of laborious animal feeding trials with diets containing
a high percentage of recombinant entomotoxin or diets
containing transgenic seeds meal [16]. In the present paper,
Cry1Ia12 toxin was included in a high biological value
diet at 100mg/Kg diet, accounting for 0.1% total protein.
The rationale for this concentration is that the expression
level in a genetically modiﬁed plant varies from 0.01%
to 0.1% of total protein content [17]. The proportion of
recombinant protein used in this study was greater than that
describedforthetestdietswithtransgenicriceCry1Abtoxin,
which was approximately 10mg/Kg diet [5], and greater
than that used in the test diets for transgenic tomato [18],
whichconsistedof10%lyophilisedtransgenictomatoextract
(40ng Cry1Ab/mg total protein), and well above that in the
test diets for cotton seed bran, which had 0.28mg Cry1F/Kg
diet and 0.096mg Cry1Ac/Kg diet [19]. Presumably, the
higher content of Cry1Ia12 used in the present study allows
a safer assessment considering the short duration of the
experiment which investigated the eﬀects of this toxin on the
nutritional performance and other health aspects of growing
rats.6 Journal of Biomedicine and Biotechnology
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Figure 2: Histological duodenum sections of rats fed standard (based on egg white) diet (a) and CryIa12 toxin-containing diet (b) (600x
ampliﬁcation). Arrow 1shows thatthe edge formedby microvilli remains intact for all treatments.Arrow 2 shows the nucleus of enterocytes,
normal in all treatments. Arrow 3shows thegoblet cells with normalsize for all treatments.Thetissues were stained withhematoxylin-eosin.
The protein Cry1Ia12 shows high identity (99%) and
high similarity (99%) with other Cry1Ia toxins deposited in
databases.Therearesubstitutionsonlyatpositions 476(afor
g) and 1719 (c for t) resulting in a single substitution of Arg
for Lys159 in domain I (localised at the second alpha-helix).
This shows that the sequences of Cry1Ia type proteins do
not diﬀer much from one another [1]. This similarity among
Cry1Ia toxins is consistent with the lack of deleterious eﬀects
of the entomotoxin evaluated in this study since several of
Cry1 toxins have been studied with regard to food safety in
mammals [5, 19].
The results of the feeding trials with rats fed a diet
containing 100mg Cry1Ia12/Kg diet showed that the growth
rate of the rats was similar to those fed the control diet (egg
white as the sole source of protein). This might be explained
by the fact that there was no diﬀerence in body weight gain,
food intake, or alimentary conversion among the diﬀerent
treatments involving test and control diets. In fact, these
results are comparable to those described by Schrøder et
al. [5] who reported similar growth rates between rats fed
transgenic rice expressing the Cry1Ab toxin and rats fed
conventional rice. Noteborn et al. [18]a n dD ry z g ae ta l .[ 19]
have also reported the same trend in rats receiving the toxin
Cry1Ab and Cry1Ac, respectively, for at least 90 days.
The lack of deleterious eﬀects of Cry entomotoxins in
mammals has been explained by stomach acidiﬁcation and
by the absence of speciﬁc binding sites for Cry toxins in
the intestine [4]. In this sense, the rapid degradation of
these proteins in gastric ﬂuid (about 90% in 2min) has
been veriﬁed. Although Cry protein degradation is slower
in the intestine, this does not have much importance for the
organism since after ingestion these proteins are hydrolysed
almost completely by pepsin in the stomach [20, 21]. Thus,
these proteins would have a much more signiﬁcant role
in supplying amino acids than in inducing other eﬀects.
Another parameter considered in the present paper was
nitrogen balance (Table 4). The ratio of dietary intake and
faecal excretion and the relative values of nitrogen excretion
of rats fed the test diet were similar to those fed the
control diet. Therefore, Cry1Ia12 at the concentration of
100mg/Kg diet was not able to interfere with egg white
proteinutilization.Therewasgoodnitrogenretention,which
can be explained by the excellent amino acid proﬁle, the high
protein digestibility and especially the lack of antinutritional
and/or toxic eﬀects of the Cry toxin included in the diet.
In order to substantiate the lack of deleterious eﬀects
of Cry protein upon dietary protein absorption, other
nutritional parameters, including digestibility, NPU, and
biological value were investigated (Table 2). All these param-
eters for the group on the diet containing Cry1Ia12 toxin
were similar to those of rats on the control diet. Almost
all the parameters were greater than or very close to 90%,
conﬁrming the lack of toxic/antinutritional eﬀects of the
Cry toxin, at least for rats. Poor digestibility is one of the
main factors that compromise the net eﬃciency of a protein,
and consequently its biological value. When some peptide
bonds are not hydrolysed, part of the protein is excreted
in faeces or transformed into metabolites by large intestine
microorganisms [22]. Thus, the rationale for the assessment
of this parameter was the concern that undigested proteins
might bind to intestinal mucosa, causing changes related to
those shown by invertebrates susceptible to Cry proteins,
such as inactivation of the system that maintains the pH
gradient [23] and osmotic cytolysis [24]. This binding could
also result in the internalisation of the protein and other
subsequent systemic eﬀects, such as changes in internal
organs reported for several lectins [22]. No diﬀerence was
detected in the relative wet or dry weight of the internal
organs of rats on the Cry1Ia12 diet when compared to those
on the control diet (Table 5). This was also reported for rats
fedontransgeniccottonexpressingtheentomotoxicproteins
Cry1F and Cry1Ac [19].Journal of Biomedicine and Biotechnology 7
In contrast to what has been reported for larvae of
susceptible insects, rats on the diet containing Cry1Ia12 did
not show any changes in intestinal epithelium which would
be indicative of injury to intestinal mucosa [25]. As a matter
of fact, it has been reported that Cry toxins do not interact
with any region of the digestive tract [18].
As for the blood biochemistry analysis, which could have
indicated signs of toxicity, no signiﬁcant change was detected
between control rats and those fed the Cry1Ia12 diet. Only
those rats on the nonprotein containing diet showed changes
inbloodparameters,whichisrelatedtoproteinmalnutrition
[12].
Cry1Ia12toxinwasalsoadministeredasasingleoraldose
(12mg) to rats, but no animal died or showed any apparent
change in behaviour. The amount of Cry1Ia12 delivered
was greater than that of other Cry proteins expressed in
genetically modiﬁed plants. For instance, the highest levels
of Cry1Ab protein in the transgenic corn MON 810 were
detected in leaves, from 4.91 to 12.5mg/kg fresh weight. In
the whole plant, the values have been reported to be in the
range of 3.34 to 4.88mg/Kg, and in grains, from 0.31 to
0.57mg/Kg fresh weight [26] .T h e s eﬁ g u r e sa r em u c hl o w e r
when related to total protein: 10.34ng/mg total protein in
leaves, 4.65ng/mg total protein in the whole plant, and from
0.19to0.39ng/mgtotalproteiningrains.Ontheotherhand,
the Cry1Ac protein, present in thirteen commercial varieties
of cotton, has shown an average level of 1.5mg/Kg protein
[27]. Therefore, the data of the present paper seem to point
to the safety of Cry1Ia12 protein when administered per os
to rats, corroborating several other studies that have shown
the lack of toxicity or any other antinutritional eﬀects of Cry
proteins in mammals [28].
5. Conclusion
In summary, Cry1Ia12 entomotoxic protein of B. thuringien-
sis when included in diets for growing rats at 100mg/kg diet
for ten days did not interfere with their nutritional perfor-
mance.Whenthetoxinwasadministeredasasingleoraldose
of12mgper animal,theratsdidnotshowanysignoftoxicity.
The results of the present study indicate the biotechnological
potential of Cry1Ia12 protein and may contribute with
relevant information that makes it an eﬀective and safe
tool for the control of important pests of cotton crops.
Nevertheless, further studies on the structural homology of
the toxin with other toxic or allergenic proteins and on the
potential toxicity of higher doses of this entomotoxin must
be conducted to ensure the safety of its use.
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